These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 6615699

  • 1. The effect of radiosensitizers on the pharmacokinetics of melphalan and cyclophosphamide in the mouse.
    Hinchliffe M, McNally NJ, Stratford MR.
    Br J Cancer; 1983 Sep; 48(3):375-83. PubMed ID: 6615699
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
    McNally NJ, Hinchliffe M, de Ronde J.
    Br J Cancer; 1983 Aug; 48(2):271-8. PubMed ID: 6882665
    [Abstract] [Full Text] [Related]

  • 3. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
    Twentyman P, Workman P.
    Br J Cancer; 1982 Mar; 45(3):447-55. PubMed ID: 7073938
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of the effect of cytotoxic drugs by radiosensitizers.
    Martin WM, McNally NJ, De Ronde J.
    Br J Cancer; 1981 Jun; 43(6):756-66. PubMed ID: 7248157
    [Abstract] [Full Text] [Related]

  • 5. Chemosensitization of mouse tumors by misonidazole.
    Randhawa VS, Stewart FA, Denekamp J.
    Int J Radiat Oncol Biol Phys; 1982 Jun; 8(3-4):671-4. PubMed ID: 7107397
    [Abstract] [Full Text] [Related]

  • 6. Factors influencing the chemosensitization of melphalan by misonidazole.
    Randhawa VS, Stewart FA, Denekamp J, Stratford MR.
    Br J Cancer; 1985 Feb; 51(2):219-28. PubMed ID: 3966979
    [Abstract] [Full Text] [Related]

  • 7. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
    Law MP, Hirst DG, Brown JM.
    Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of the DNA cross-linking activity of melphalan by misonidazole in vivo.
    Murray D, Meyn RE.
    Br J Cancer; 1983 Feb; 47(2):195-203. PubMed ID: 6824567
    [Abstract] [Full Text] [Related]

  • 9. Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
    Brown JM, Hirst DG.
    Br J Cancer; 1982 May; 45(5):700-8. PubMed ID: 7082556
    [Abstract] [Full Text] [Related]

  • 10. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
    Lee FY, Workman P.
    Br J Cancer; 1983 May; 47(5):659-69. PubMed ID: 6849803
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
    Horsman MR, Evans JW, Brown JM.
    Br J Cancer; 1984 Sep; 50(3):305-16. PubMed ID: 6466544
    [Abstract] [Full Text] [Related]

  • 12. Altered pharmacokinetics in the mechanism of chemosensitization: effects of nitroimidazoles and other chemical modifiers on the pharmacokinetics, antitumour activity and acute toxicity of selected nitrogen mustards.
    Lee FY, Workman P.
    Cancer Chemother Pharmacol; 1986 Sep; 17(1):30-7. PubMed ID: 3698174
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of cytotoxic drugs by misonidazole (MISO) in Lewis lung tumors of different sizes, and mouse bone marrow.
    Spooner D, Peacock JH, Stephens TC.
    Int J Radiat Oncol Biol Phys; 1982 Sep; 8(3-4):643-6. PubMed ID: 7107390
    [Abstract] [Full Text] [Related]

  • 14. Enhancing effect of pre-treatment of cells with misonidazole in hypoxia on their response to melphalan in air.
    Smith E, Stratford IJ, Adams GE.
    Br J Cancer; 1982 Jul; 46(1):117-26. PubMed ID: 7104191
    [Abstract] [Full Text] [Related]

  • 15. Studies on the mechanism of chemosensitization by misonidazole in vitro.
    Taylor YC, Bump EA, Brown JM.
    Int J Radiat Oncol Biol Phys; 1982 Jul; 8(3-4):705-8. PubMed ID: 7107402
    [Abstract] [Full Text] [Related]

  • 16. Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069.
    Siemann DW, Maddison K, Wolf K.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1657-60. PubMed ID: 6548212
    [Abstract] [Full Text] [Related]

  • 17. An investigation of the possibility of chemosensitization by clinically achievable concentrations of misonidazole.
    Twentyman PR, Workman P.
    Br J Cancer; 1983 Feb; 47(2):187-94. PubMed ID: 6824566
    [Abstract] [Full Text] [Related]

  • 18. Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.
    Roizin-Towle LA, Hall EJ.
    Br J Cancer; 1981 Aug; 44(2):201-7. PubMed ID: 6168277
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
    Hirst DG, Brown JM, Hazlehurst JL.
    Br J Cancer; 1982 Jul; 46(1):109-16. PubMed ID: 7201845
    [Abstract] [Full Text] [Related]

  • 20. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
    Milas L, Ito H, Hunter N.
    Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.